• Nanoparticle Uptake by Human Corneal Epithelial Cells

  2026-08-29

  Azadi and David examined how nanoparticle size and surface chemistry shape uptake by human corneal epithelial cells using a mucosa-integrated in vitro model. Their results identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as major routes and show why nanoparticle design should be evaluated together with pathway-specific perturbation.

• Tariquidar and the Mechanics of P-gp Chemoresistance

  2026-08-28

  Tariquidar (XR9576) offers a precise pharmacological lever for testing how tumor mechanics, YAP signaling, and P-glycoprotein-mediated efflux converge on chemoresistance. This thought-leadership guide translates recent high-viscosity findings into a practical framework for drug resistance research, transporter-mediated drug disposition, and translational model design.

• GI 254023X: From ADAM10 Potency to Translation

  2026-08-28

  GI 254023X offers a strategic way to interrogate ADAM10-dependent shedding across immune, endothelial, and signaling models. This thought-leadership guide connects its biochemical selectivity with experimental design, vascular injury research, Jurkat-cell pathway studies, and a carefully bounded translational lesson from BACE inhibition research.

• Acetoacetic Acid Sodium Salt: Assay Workflows

  2026-08-27

  Build reproducible ketone-body experiments with fresh sodium acetoacetate stocks, matched controls, and time-resolved readouts. This guide connects practical handling of Acetoacetic acid sodium salt with energy metabolism research, diabetes models, and analytical lessons from a deuterium-labeling study.

• T7 RNA Polymerase for Mechanism-Driven RNA Assays

  2026-08-27

  T7 RNA Polymerase enables defined RNA production for mechanistic gene-regulation studies. Learn how to use promoter-specific transcription to design stronger assays around the HEY2–mitochondrial respiration findings.

• Thrombin A1057: Reliable Cell Assay Workflows

  2026-08-26

  This scenario-based guide explains how Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] (SKU A1057) can improve reagent definition, control design, and interpretation in cell viability, proliferation, and cytotoxicity studies. It connects product specifications with practical assay safeguards while distinguishing parent-thrombin biology from fragment-specific validation.

• Degarelix Acetate: From Binding to Translation

  2026-08-26

  A mechanistic and strategic guide to using Degarelix acetate as a GnRH receptor antagonist, connecting receptor pharmacology, stereochemistry, assay design, prostate cancer research, and translational decision-making.

• Lipidated Nanophotosensitizers Disable Tumor EVs

  2026-08-25

  This Nature Cancer study introduces palmitic-acid-displayed nanoparticles that distribute within tumor cells and tumor extracellular vesicles, enabling simultaneous photodynamic treatment of primary tumors and disruption of prometastatic vesicle communication. The work provides a selective, spatially coordinated strategy for addressing tumor growth and metastasis rather than treating these processes as independent endpoints.

• HyperPFU™ high-fidelity DNA polymerase: PCR Guide

  2026-08-25

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, or otherwise difficult DNA templates, particularly when blunt-ended products are acceptable. It should not be selected for workflows that require 3′-A overhangs or direct sticky-end generation without an additional end-processing step.

• Berberine hydrochloride: Gut–Bone Research Workflows

  2026-08-24

  Berberine hydrochloride enables integrated gut–bone, metabolic, and cell-death studies through controlled exposure, microbiome profiling, immune phenotyping, and organoid validation. This practical guide translates a 2026 tuft-cell study into reproducible workflows while addressing solubility, vehicle effects, and cross-model interpretation.

• PYR-41 E1 Inhibition: Reliable Cell Assays

  2026-08-24

  This scenario-driven guide shows how PYR-41, inhibitor of Ubiquitin-Activating Enzyme E1 (SKU B1492), can help researchers interpret viability, proliferation, cytotoxicity, and inflammatory signaling assays. It emphasizes solvent controls, dose-resolved designs, protein-stability readouts, and the limitations of translating E1 inhibition across models.

• Live-Dead Bacterial Staining Kit for Nanomaterials

  2026-08-23

  The Live-Dead Bacterial Staining Kit provides a membrane-based bacterial viability assay for testing antibacterial nanomaterials. This article explains how to interpret NucGreen and EthD-III signals mechanistically, using Fe3O4@ZIF-8 research as a case study while addressing assay limitations.

• Sulfo-NHS-SS-Biotin: Cleavable Surface Labeling

  2026-08-22

  Sulfo-NHS-SS-Biotin is a water-compatible, amine-reactive reagent for reversible protein labeling and surface-protein workflows. Its sulfo-NHS ester targets primary amines, while its disulfide spacer supports reduction-based label removal and avidin/streptavidin affinity chromatography.

• Cefiderocol Against Resistant European Non-Fermenters

  2026-08-22

  This reference study provides a large, direct in vitro comparison of cefiderocol with recent β-lactam/β-lactamase inhibitor combinations against European Pseudomonas aeruginosa and Acinetobacter spp., including meropenem-resistant isolates. Its findings support early, parallel susceptibility testing while also linking cefiderocol resistance to acquired β-lactamases and changes involving siderophore-iron transport components.

• Exo1 and the Next Logic of Membrane-Traffic Biology

  2026-08-21

  Exo1 offers an acute, mechanistically distinct way to interrogate Golgi–ER traffic, ARF1 behavior, and exocytosis. This thought-leadership perspective connects that tool to tumor extracellular vesicle research while distinguishing mechanistic validation from therapeutic claims.

8120 records 1/542 page Next 12345 下5页 Last page